Company: AEMD
Filing Date: 2025-08-20
Form Type: S-1
Source: 0001683168-25-006352
Chunk: 57

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-20
Form: S-1
Chunk 57
---
is Computershare Investor Services. The transfer agent’s address is P.O. Box 30170, College Station, TX 77842.

| 33 |

<div align='center'>DESCRIPTION OF SECURITIES</div>

Company Offering

We are offering (i) up to [__] shares of our common stock or pre-funded warrants and (ii) warrants to purchase up to an aggregate of [__] shares of our common stock. Each share of common stock or pre-funded warrant is being sold together with a warrant to purchase one share of common stock. The shares of common stock or pre-funded warrants and accompanying warrants will be issued separately. We are also registering the shares of common stock issuable from time to time upon exercise of the pre-funded warrants and warrants offered hereby.

Common Stock

The material terms and provisions
of our common stock and each other class of our securities which, if designated and issued, qualifies or limits our common stock are described
under the caption “Description of Capital Stock” in this prospectus.

Pre-Funded Warrants

The following
summary of certain terms and provisions of the pre-funded warrants that are being offered hereby is not complete and is subject to, and
qualified in its entirety by the provisions of, the pre-funded warrant. Prospective investors should carefully review the terms and provisions
of the form of pre-funded warrant for a complete description of the terms and conditions of the pre-funded warrants.

The term
“pre-funded” refers to the fact that the purchase price of each pre-funded warrant, at closing, will equal the price
per share at which shares of our common stock and accompanying warrants to purchase common stock are being sold to the public in this
offering, minus $0.001, and the exercise price of each pre-funded warrant will equal $0.001 per share of common stock. The purpose of
the pre-funded warrants is to enable investors that may have restrictions on their ability to beneficially own more than 4.99%
(or, upon election of the holder, 9.99%) of our outstanding common stock following the consummation of this offering the opportunity to
invest capital into us without triggering their ownership restrictions, by receiving pre-funded warrants in lieu of our common
stock to the extent it would result in such ownership of more than 4.99% (or 9.99%), and receive the ability to purchase the shares underlying
the pre-funded warrants at such nominal price at a later date.

Duration.
The pre-funded warrants offered hereby will